Share Price and Basic Stock Data
Last Updated: January 28, 2026, 12:03 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
HB Portfolio Ltd operates in the finance and investments sector, with a current market capitalization of ₹64.6 Cr and a share price of ₹60.0. The company reported sales of ₹23.06 Cr for the fiscal year ending March 2023, which rose significantly to ₹54.77 Cr for the fiscal year ending March 2024. However, the trailing twelve months (TTM) revenue stands at ₹25.66 Cr, indicating a decline from the peak achieved in the previous fiscal year. Quarterly sales demonstrated fluctuations, peaking at ₹37.32 Cr in March 2024 before declining to ₹5.06 Cr in September 2024. The inconsistent revenue trends could raise concerns about operational stability, despite the reported increase in sales over the longer term. The company’s total assets stood at ₹289.12 Cr as of March 2025, reflecting a robust asset base but also highlighting the need for efficient asset utilization in generating revenue.
Profitability and Efficiency Metrics
HB Portfolio Ltd’s profitability metrics reveal significant volatility. For the fiscal year ending March 2025, the net profit reported was a mere ₹-0.04 Cr, compared to ₹3.06 Cr in March 2023 and ₹7.02 Cr in March 2024. Consequently, the earnings per share (EPS) declined to ₹-0.04 in March 2025 from ₹4.80 in March 2024, indicating a challenging year for earnings generation. The operating profit margin (OPM) for the latest fiscal year was recorded at 10.83%, down from 38.23% in March 2022. The company’s return on equity (ROE) stood at 0.02% and return on capital employed (ROCE) at 0.80%, both of which are notably low compared to typical industry benchmarks. This underperformance in profitability underscores the need for operational improvements and strategic adjustments to enhance efficiency and profitability.
Balance Sheet Strength and Financial Ratios
On the balance sheet front, HB Portfolio Ltd shows a healthy reserve position with ₹269.11 Cr in reserves as of September 2025. The company’s borrowings are minimal at ₹0.68 Cr, indicating low financial leverage. The interest coverage ratio (ICR) stands at 9.85x, suggesting that the company comfortably meets its interest obligations. However, the price-to-book value (P/BV) ratio is low at 0.34x, raising questions about market perceptions of the company’s intrinsic value relative to its book value. The current ratio is exceptionally high at 37.73, indicating a strong liquidity position. However, the cash conversion cycle (CCC) of 13.69 days is relatively low, suggesting the company efficiently manages its cash flow cycle. Overall, while the balance sheet indicates strength in liquidity and low debt levels, the low P/BV ratio may reflect market skepticism about future profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of HB Portfolio Ltd shows a significant promoter holding of 61.45%, suggesting strong control by the founding members, which can instill confidence among investors. However, foreign institutional investors (FIIs) have not shown interest, and domestic institutional investors (DIIs) hold a mere 0.02%, indicating a lack of institutional backing. The public shareholding stands at 38.53%, with the total number of shareholders reported at 62,615. This distribution may signal limited investor diversification, as a high promoter stake could lead to governance issues if not managed properly. The declining number of shareholders from 64,958 in March 2023 to 62,615 in December 2025 may raise concerns about investor confidence and market sentiment towards the stock, particularly in light of recent financial performance.
Outlook, Risks, and Final Insight
Looking ahead, HB Portfolio Ltd faces a mixed outlook characterized by both strengths and risks. The company’s significant reserves and low debt levels position it favorably for potential growth opportunities. However, the persistent volatility in profitability metrics, highlighted by declining net profits and low ROE, presents substantial risks. Furthermore, the lack of institutional interest could hinder future capital raising efforts and limit stock liquidity. The company must focus on operational efficiencies and strategic initiatives to enhance profitability and restore investor confidence. If the firm can stabilize its earnings and improve its financial metrics, it may attract greater institutional interest and potentially enhance its market valuation. Conversely, continued underperformance could lead to further erosion of shareholder value and market sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.4 Cr. | 39.0 | 57.0/36.4 | 45.7 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,190 Cr. | 276 | 455/269 | 13.6 | 111 | 0.37 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 28.8 Cr. | 0.41 | 1.23/0.38 | 3.99 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.75 Cr. | 7.58 | 11.6/7.58 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 17.9 Cr. | 34.8 | 69.9/34.8 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,072.32 Cr | 1,245.48 | 67.58 | 3,844.55 | 0.38% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.84 | 10.69 | 2.49 | 4.85 | 5.88 | 5.98 | 37.32 | 8.75 | 5.06 | 9.73 | 4.30 | 7.70 | 3.93 |
| Expenses | 2.48 | 8.90 | 4.20 | 3.26 | 3.06 | 3.18 | 36.61 | 3.93 | 4.81 | 10.29 | 6.16 | 4.09 | 3.77 |
| Operating Profit | 1.36 | 1.79 | -1.71 | 1.59 | 2.82 | 2.80 | 0.71 | 4.82 | 0.25 | -0.56 | -1.86 | 3.61 | 0.16 |
| OPM % | 35.42% | 16.74% | -68.67% | 32.78% | 47.96% | 46.82% | 1.90% | 55.09% | 4.94% | -5.76% | -43.26% | 46.88% | 4.07% |
| Other Income | 0.01 | 0.01 | -0.01 | 0.21 | 0.00 | 0.08 | 0.72 | 0.11 | 0.14 | 0.09 | 0.11 | 0.05 | 0.05 |
| Interest | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.10 | 0.04 | 0.04 | 0.21 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 | 0.09 | 0.47 | 0.17 | 0.17 | 0.18 | 0.30 | 0.21 | 0.21 |
| Profit before tax | 1.26 | 1.69 | -1.82 | 1.67 | 2.69 | 2.77 | 0.86 | 4.72 | 0.18 | -0.86 | -2.07 | 3.43 | -0.02 |
| Tax % | -9.52% | 2.96% | 26.37% | 33.53% | 25.28% | 42.96% | 43.02% | 30.51% | 216.67% | 19.77% | -12.56% | 37.90% | -100.00% |
| Net Profit | 1.45 | 1.65 | -2.27 | 1.00 | 2.51 | 2.02 | 1.52 | 3.48 | 0.40 | -0.86 | -3.06 | 2.20 | 0.08 |
| EPS in Rs | 1.35 | 1.53 | -2.11 | 0.92 | 2.33 | 1.88 | 1.41 | 3.22 | 0.37 | -0.80 | -2.84 | 2.03 | 0.07 |
Last Updated: January 7, 2026, 12:37 am
Below is a detailed analysis of the quarterly data for HB Portfolio Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3.93 Cr.. The value appears to be declining and may need further review. It has decreased from 7.70 Cr. (Jun 2025) to 3.93 Cr., marking a decrease of 3.77 Cr..
- For Expenses, as of Sep 2025, the value is 3.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.09 Cr. (Jun 2025) to 3.77 Cr., marking a decrease of 0.32 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 3.61 Cr. (Jun 2025) to 0.16 Cr., marking a decrease of 3.45 Cr..
- For OPM %, as of Sep 2025, the value is 4.07%. The value appears to be declining and may need further review. It has decreased from 46.88% (Jun 2025) to 4.07%, marking a decrease of 42.81%.
- For Other Income, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.05 Cr..
- For Interest, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.21 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.21 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 3.43 Cr. (Jun 2025) to -0.02 Cr., marking a decrease of 3.45 Cr..
- For Tax %, as of Sep 2025, the value is -100.00%. The value appears to be improving (decreasing) as expected. It has decreased from 37.90% (Jun 2025) to -100.00%, marking a decrease of 137.90%.
- For Net Profit, as of Sep 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 2.20 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 2.12 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 2.03 (Jun 2025) to 0.07, marking a decrease of 1.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.38 | 3.04 | 2.24 | 3.31 | 31.52 | 14.10 | 14.61 | 21.47 | 18.57 | 23.06 | 54.77 | 28.26 | 25.66 |
| Expenses | 1.79 | 1.82 | 2.05 | 2.85 | 17.20 | 16.95 | 19.68 | 16.44 | 11.47 | 19.10 | 46.10 | 25.20 | 24.31 |
| Operating Profit | 6.59 | 1.22 | 0.19 | 0.46 | 14.32 | -2.85 | -5.07 | 5.03 | 7.10 | 3.96 | 8.67 | 3.06 | 1.35 |
| OPM % | 78.64% | 40.13% | 8.48% | 13.90% | 45.43% | -20.21% | -34.70% | 23.43% | 38.23% | 17.17% | 15.83% | 10.83% | 5.26% |
| Other Income | 0.14 | 0.06 | 0.01 | 0.01 | 0.27 | 1.04 | 0.10 | -0.01 | -0.01 | 0.04 | 0.26 | 0.03 | 0.30 |
| Interest | 0.22 | 0.39 | 0.11 | 0.04 | 0.05 | 0.05 | 0.04 | 0.02 | 0.05 | 0.09 | 0.17 | 0.31 | 0.27 |
| Depreciation | -0.01 | 0.19 | 0.07 | 0.06 | 0.30 | 0.28 | 0.27 | 0.28 | 0.31 | 0.36 | 0.79 | 0.83 | 0.90 |
| Profit before tax | 6.52 | 0.70 | 0.02 | 0.37 | 14.24 | -2.14 | -5.28 | 4.72 | 6.73 | 3.55 | 7.97 | 1.95 | 0.48 |
| Tax % | 23.16% | 51.43% | 550.00% | 24.32% | 18.61% | -0.93% | 1.52% | 6.78% | 6.69% | 16.90% | 35.26% | 89.74% | |
| Net Profit | 1.34 | -4.31 | 6.46 | 3.16 | 11.66 | -2.74 | -5.31 | 4.52 | 6.46 | 3.06 | 7.02 | -0.04 | -1.64 |
| EPS in Rs | 1.12 | -3.59 | 5.38 | 2.63 | 10.37 | -2.29 | -3.16 | 3.30 | 6.00 | 2.84 | 6.52 | -0.05 | -1.54 |
| Dividend Payout % | 137.35% | -14.23% | 9.50% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 28.86% | 15.73% | -2,208.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -421.64% | 249.88% | -51.08% | 268.99% | -123.50% | -93.80% | 185.12% | 42.92% | -52.63% | 129.41% | -100.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | 671.53% | -300.97% | 320.07% | -392.49% | 29.70% | 278.92% | -142.20% | -95.55% | 182.04% | -229.98% |
HB Portfolio Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | -54% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | % |
| TTM: | -114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 35% |
| 3 Years: | 30% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: December 4, 2025, 3:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.27 | 12.27 | 12.27 | 12.27 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 | 11.04 |
| Reserves | 113.48 | 108.45 | 114.18 | 117.35 | 128.08 | 144.27 | 115.19 | 143.43 | 194.18 | 181.14 | 274.83 | 265.48 | 269.11 |
| Borrowings | 4.60 | 3.08 | 2.43 | 2.34 | 2.48 | 0.27 | 0.09 | 0.06 | 1.02 | 0.84 | 1.76 | 1.06 | 0.68 |
| Other Liabilities | 8.83 | 9.57 | 4.95 | 5.47 | 27.87 | 27.04 | 25.04 | 9.06 | 10.34 | 2.77 | 13.97 | 11.54 | 11.61 |
| Total Liabilities | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 | 292.44 |
| Fixed Assets | 0.51 | 0.33 | 0.28 | 0.23 | 2.49 | 0.82 | 0.82 | 0.63 | 1.91 | 1.67 | 2.49 | 1.95 | 204.64 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 75.47 | 72.27 | 78.68 | 85.17 | 86.02 | 121.26 | 81.88 | 101.83 | 139.31 | 127.32 | 246.89 | 232.55 | 50.74 |
| Other Assets | 63.20 | 60.77 | 54.87 | 52.03 | 80.96 | 60.54 | 68.66 | 61.13 | 75.36 | 66.80 | 52.22 | 54.62 | 37.06 |
| Total Assets | 139.18 | 133.37 | 133.83 | 137.43 | 169.47 | 182.62 | 151.36 | 163.59 | 216.58 | 195.79 | 301.60 | 289.12 | 292.44 |
Below is a detailed analysis of the balance sheet data for HB Portfolio Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.04 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.04 Cr..
- For Reserves, as of Sep 2025, the value is 269.11 Cr.. The value appears strong and on an upward trend. It has increased from 265.48 Cr. (Mar 2025) to 269.11 Cr., marking an increase of 3.63 Cr..
- For Borrowings, as of Sep 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.06 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.38 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.54 Cr. (Mar 2025) to 11.61 Cr., marking an increase of 0.07 Cr..
- For Total Liabilities, as of Sep 2025, the value is 292.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 289.12 Cr. (Mar 2025) to 292.44 Cr., marking an increase of 3.32 Cr..
- For Fixed Assets, as of Sep 2025, the value is 204.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.95 Cr. (Mar 2025) to 204.64 Cr., marking an increase of 202.69 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 50.74 Cr.. The value appears to be declining and may need further review. It has decreased from 232.55 Cr. (Mar 2025) to 50.74 Cr., marking a decrease of 181.81 Cr..
- For Other Assets, as of Sep 2025, the value is 37.06 Cr.. The value appears to be declining and may need further review. It has decreased from 54.62 Cr. (Mar 2025) to 37.06 Cr., marking a decrease of 17.56 Cr..
- For Total Assets, as of Sep 2025, the value is 292.44 Cr.. The value appears strong and on an upward trend. It has increased from 289.12 Cr. (Mar 2025) to 292.44 Cr., marking an increase of 3.32 Cr..
Notably, the Reserves (269.11 Cr.) exceed the Borrowings (0.68 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.99 | -1.86 | -2.24 | -1.88 | 11.84 | -3.12 | -5.16 | 4.97 | 6.08 | 3.12 | 6.91 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 43.12 | 0.00 | 0.00 | 0.00 | 10.89 | 18.12 | 4.75 | 13.26 | 18.08 | 12.03 | 35.65 | 13.69 |
| Working Capital Days | 1,802.35 | 4,740.20 | 6,627.03 | 4,053.60 | 651.37 | 267.15 | 239.84 | 158.95 | 147.42 | 126.31 | 210.19 | 342.91 |
| ROCE % | 5.13% | 0.86% | 0.10% | 0.31% | 9.88% | -1.76% | -3.29% | 3.19% | 3.76% | 1.82% | 3.33% | 0.80% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
| Diluted EPS (Rs.) | -0.04 | 4.80 | 2.73 | 5.83 | 4.09 |
| Cash EPS (Rs.) | 0.93 | 5.39 | 2.99 | 5.97 | 4.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 250.52 | 259.35 | 174.45 | 186.26 | 140.28 |
| Revenue From Operations / Share (Rs.) | 25.22 | 48.95 | 20.89 | 16.82 | 19.45 |
| PBDIT / Share (Rs.) | 2.81 | 8.09 | 3.60 | 6.41 | 4.54 |
| PBIT / Share (Rs.) | 2.05 | 7.38 | 3.27 | 6.12 | 4.28 |
| PBT / Share (Rs.) | 1.77 | 7.22 | 3.21 | 6.09 | 4.28 |
| Net Profit / Share (Rs.) | 0.18 | 4.68 | 2.67 | 5.68 | 3.99 |
| NP After MI And SOA / Share (Rs.) | -0.04 | 6.36 | 2.77 | 5.85 | 3.21 |
| PBDIT Margin (%) | 11.12 | 16.52 | 17.22 | 38.07 | 23.33 |
| PBIT Margin (%) | 8.14 | 15.06 | 15.65 | 36.39 | 22.01 |
| PBT Margin (%) | 7.01 | 14.75 | 15.38 | 36.22 | 21.97 |
| Net Profit Margin (%) | 0.74 | 9.56 | 12.76 | 33.79 | 20.49 |
| NP After MI And SOA Margin (%) | -0.19 | 12.99 | 13.25 | 34.76 | 16.51 |
| Return on Networth / Equity (%) | -0.01 | 2.45 | 1.59 | 3.14 | 2.29 |
| Return on Capital Employeed (%) | 0.79 | 2.73 | 1.85 | 3.14 | 2.90 |
| Return On Assets (%) | -0.01 | 2.32 | 1.56 | 2.98 | 2.16 |
| Asset Turnover Ratio (%) | 0.09 | 0.21 | 0.11 | 0.01 | 0.04 |
| Current Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
| Quick Ratio (X) | 37.73 | 80.61 | 129.49 | 124.98 | 168.33 |
| Dividend Payout Ratio (NP) (%) | -2034.78 | 15.32 | 28.17 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 138.60 | 13.78 | 25.19 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 2134.78 | 84.68 | 71.83 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | -38.60 | 86.22 | 74.81 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.85 | 52.12 | 63.65 | 222.25 | 688.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.66 | 31.18 | 48.18 | 198.25 | 605.30 |
| Enterprise Value (Cr.) | 89.11 | 57.65 | 30.47 | 23.12 | 16.30 |
| EV / Net Operating Revenue (X) | 3.20 | 1.07 | 1.32 | 1.25 | 0.75 |
| EV / EBITDA (X) | 28.78 | 6.46 | 7.67 | 3.27 | 3.25 |
| MarketCap / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
| Retention Ratios (%) | 2134.78 | 84.67 | 71.82 | 0.00 | 0.00 |
| Price / BV (X) | 0.34 | 0.23 | 0.21 | 0.17 | 0.13 |
| Price / Net Operating Revenue (X) | 3.43 | 1.23 | 1.80 | 1.96 | 0.97 |
| EarningsYield | 0.00 | 0.10 | 0.07 | 0.17 | 0.16 |
After reviewing the key financial ratios for HB Portfolio Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 4.80 (Mar 24) to -0.04, marking a decrease of 4.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 3. It has decreased from 5.39 (Mar 24) to 0.93, marking a decrease of 4.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 250.52. It has decreased from 259.35 (Mar 24) to 250.52, marking a decrease of 8.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.22. It has decreased from 48.95 (Mar 24) to 25.22, marking a decrease of 23.73.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.81. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 2.81, marking a decrease of 5.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.05. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 2.05, marking a decrease of 5.33.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 1.77, marking a decrease of 5.45.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 2. It has decreased from 4.68 (Mar 24) to 0.18, marking a decrease of 4.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 2. It has decreased from 6.36 (Mar 24) to -0.04, marking a decrease of 6.40.
- For PBDIT Margin (%), as of Mar 25, the value is 11.12. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 11.12, marking a decrease of 5.40.
- For PBIT Margin (%), as of Mar 25, the value is 8.14. This value is below the healthy minimum of 10. It has decreased from 15.06 (Mar 24) to 8.14, marking a decrease of 6.92.
- For PBT Margin (%), as of Mar 25, the value is 7.01. This value is below the healthy minimum of 10. It has decreased from 14.75 (Mar 24) to 7.01, marking a decrease of 7.74.
- For Net Profit Margin (%), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 9.56 (Mar 24) to 0.74, marking a decrease of 8.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 8. It has decreased from 12.99 (Mar 24) to -0.19, marking a decrease of 13.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 15. It has decreased from 2.45 (Mar 24) to -0.01, marking a decrease of 2.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 10. It has decreased from 2.73 (Mar 24) to 0.79, marking a decrease of 1.94.
- For Return On Assets (%), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to -0.01, marking a decrease of 2.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has decreased from 0.21 (Mar 24) to 0.09, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 3. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Quick Ratio (X), as of Mar 25, the value is 37.73. This value exceeds the healthy maximum of 2. It has decreased from 80.61 (Mar 24) to 37.73, marking a decrease of 42.88.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -2,034.78. This value is below the healthy minimum of 20. It has decreased from 15.32 (Mar 24) to -2,034.78, marking a decrease of 2,050.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 138.60. This value exceeds the healthy maximum of 50. It has increased from 13.78 (Mar 24) to 138.60, marking an increase of 124.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.68 (Mar 24) to 2,134.78, marking an increase of 2,050.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -38.60. This value is below the healthy minimum of 40. It has decreased from 86.22 (Mar 24) to -38.60, marking a decrease of 124.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has decreased from 52.12 (Mar 24) to 9.85, marking a decrease of 42.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 3. It has decreased from 31.18 (Mar 24) to 1.66, marking a decrease of 29.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 89.11. It has increased from 57.65 (Mar 24) to 89.11, marking an increase of 31.46.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has increased from 1.07 (Mar 24) to 3.20, marking an increase of 2.13.
- For EV / EBITDA (X), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 15. It has increased from 6.46 (Mar 24) to 28.78, marking an increase of 22.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For Retention Ratios (%), as of Mar 25, the value is 2,134.78. This value exceeds the healthy maximum of 70. It has increased from 84.67 (Mar 24) to 2,134.78, marking an increase of 2,050.11.
- For Price / BV (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.34, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has increased from 1.23 (Mar 24) to 3.43, marking an increase of 2.20.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HB Portfolio Ltd:
- Net Profit Margin: 0.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.79% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.01% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.66
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 37.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 67.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | Plot No. 31, Gurgaon Haryana 122001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Lalit Bhasin | Chairman |
| Mr. Anil Goyal | Managing Director |
| Mrs. Anita Jain | Director |
| Mr. Gurjot Singh Narang | Director |
| Mr. Harbans Lal | Director |
FAQ
What is the intrinsic value of HB Portfolio Ltd?
HB Portfolio Ltd's intrinsic value (as of 28 January 2026) is ₹0.41 which is 99.31% lower the current market price of ₹59.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹63.5 Cr. market cap, FY2025-2026 high/low of ₹110/56.0, reserves of ₹269.11 Cr, and liabilities of ₹292.44 Cr.
What is the Market Cap of HB Portfolio Ltd?
The Market Cap of HB Portfolio Ltd is 63.5 Cr..
What is the current Stock Price of HB Portfolio Ltd as on 28 January 2026?
The current stock price of HB Portfolio Ltd as on 28 January 2026 is ₹59.0.
What is the High / Low of HB Portfolio Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HB Portfolio Ltd stocks is ₹110/56.0.
What is the Stock P/E of HB Portfolio Ltd?
The Stock P/E of HB Portfolio Ltd is .
What is the Book Value of HB Portfolio Ltd?
The Book Value of HB Portfolio Ltd is 260.
What is the Dividend Yield of HB Portfolio Ltd?
The Dividend Yield of HB Portfolio Ltd is 1.71 %.
What is the ROCE of HB Portfolio Ltd?
The ROCE of HB Portfolio Ltd is 0.80 %.
What is the ROE of HB Portfolio Ltd?
The ROE of HB Portfolio Ltd is 0.02 %.
What is the Face Value of HB Portfolio Ltd?
The Face Value of HB Portfolio Ltd is 10.0.